New @NICEcomms medical technologies guidance recommends Leukomed Sorbact wound care dressing should be considered by @NHS as an option for preventing SSI in wounds with low to moderate exudate after caesarean section and vascular surgery. For more visit https://t.co/CXI471RYik
Its #AMRAwarenessWeek - so here's an exemplar model showcasing how implementation of a non-medicated antimicrobial dressing to prevent SSIs has also reduced the need for further antibiotics to treat wound infection by 30%⬇️ 👏👏#AMSinwoundcare#LeukomedSorbact#SSIprevention
Its #AMRAwarenessWeek - so here's an exemplar model showcasing how implementation of a non-medicated antimicrobial dressing to prevent SSIs has also reduced the need for further antibiotics to treat wound infection by 30%⬇️ 📷 #LeukomedSorbact#SSIprevention
Today is #StopWoundInfectionDay. #SSIs are the third most commonly reported type of healthcare-acquired infection and the most costly. #Leukomed#Sorbact is clinically proven to reduce #SSI rates.
New @NICEcomms medical technologies guidance recommends Leukomed Sorbact wound care dressing should be considered by @NHS as an option for preventing SSI in wounds with low to moderate exudate after caesarean section and vascular surgery. For more visit https://t.co/CXI471RYik
#SSIs are the third most commonly reported type of healthcare-acquired infection and the most costly. The clinical evidence considered by NICE suggests that Leukomed Sorbact can #reduce#SSI#risk in patients post caesarean section by up to 67% versus standard of care.
Within #vascular surgery, #SSI may complicate up to 40% of procedures (Totty et al 2020). NICE MTG55 Evidence supports the case for adopting Leukomed Sorbact for closed surgical wounds after vascular surgery. https://t.co/IBnU73HL0H
Pleased to share our educational platform PATH (Professional Accredited Training for Healthcare Professionals), covering several Therapy Areas. https://t.co/i7Iou7HkdS via @YouTube#education#healthcare
Another week and another #LeukomedSorbact implementation. This time with @CV_UHB & @suzannehardacr1. We really enjoyed meeting the lovely maternity team in Cardiff and look forward to demonstrating reductions in SSIs following C-Section procedures. #NICEMTG55#patientsafety#SSIs
Another great Best Practice Statement by @Wounds_UK "This document aims to highlight this issue and provide clinicians with practical guidance to aid accurate assessment and diagnosis in all skin tones, optimising patient care and improving outcomes."
https://t.co/RmtHlJEBJw
Our @ABUHB_Maternity teams are always looking at ways to improve their services. After introducing Leukomed Sorbat as a new wound dressing for C-Section patients, they have reduced the post C-section Surgical Site Infection (SSI) rate from 5.95% to 2.68% 👉https://t.co/b77lveDehb
Excited to share the news that @essity has been shortlisted for “Most Effective Contribution to Patient Safety” at the HSJ Partnership Awards 2022. #ReductingSSIs#LeukomedSorbact
Great to hear @Essity has been shortlisted for Most Effective Contribution to Patient Safety at the @HSJ_Awards. Collaborating with @HullYorkMed#Vascular over 7 years to demonstrate how #LeukomedSorbact can play a role in reducing #SSIs & improve outcomes for patients & the NHS
https://t.co/72jL3AuqCz
UK health officials recently warned antimicrobial resistance (AMR) was a "hidden pandemic" that could emerge in the wake of Covid-19 unless antibiotics were prescribed responsibly.
Learn more about the role of #AMS in #wound#care https://t.co/GU2Cl7CeqQ